CDLX Cardlytics
- 14.700
- +0.730+5.23%
Cardlytics News
Cardlytics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ATLANTA, May 02, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ:CDLX), an advertising platform in banks' digital channels, today announced that, on May 1, 2024, the Compensation Committee of Cardlytics' Board of
Cardlytics (NASDAQ:CDLX) Shareholders Are up 13% This Past Week, but Still in the Red Over the Last Three Years
Cardlytics, Inc. (NASDAQ:CDLX) shareholders will doubtless be very grateful to see the share price up 70% in the last quarter. But the last three years have seen a terrible decline. The share pric
Cardlytics (CDLX) Receives a Buy From Craig-Hallum
Cardlytics Insider Sold Shares Worth $278,885, According to a Recent SEC Filing
Amit Gupta, Chief Operating Officer, on April 24, 2024, sold 23,416 shares in Cardlytics (CDLX) for $278,885. Following the Form 4 filing with the SEC, Gupta has control over a total of 122,676 shares
Cardlytics Inc (CDLX) COO Amit Gupta Sells 23,416 Shares
Cardlytics Announces Timing of Its First Quarter 2024 Earnings Release
ATLANTA, April 24, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced that its first quarter ended March 31, 2024 financial
Press Release: Liane Hornsey Appointed to Cardlytics Board of Directors
Liane Hornsey Appointed to Cardlytics Board of Directors ATLANTA, April 09, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, is excited to announce the appoin
The Analyst Verdict: Cardlytics In The Eyes Of 5 Experts
5 analysts have expressed a variety of opinions on Cardlytics (NASDAQ:CDLX) over the past quarter, offering a diverse set of opinions from bullish to bearish.The table below summarizes their recent ra
Cardlytics Is Maintained at Buy by Needham
Cardlytics Is Maintained at Buy by Needham
Express News | Needham Maintains Buy on Cardlytics, Raises Price Target to $17
Cardlytics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/09/2024 24% Needham $15 → $17 Maintains Buy 03/15/2024 31.29% Lake Street $13 → $18 Maintains Buy 03/15
Buy Rating Reaffirmed for Cardlytics Amid Growth Prospects and Strategic American Express Partnership
Is There An Opportunity With Cardlytics, Inc.'s (NASDAQ:CDLX) 31% Undervaluation?
Craig-Hallum Reaffirms Their Buy Rating on Cardlytics (CDLX)
Cardlytics Insider Sold Shares Worth $448,020, According to a Recent SEC Filing
Temsamani Karim Saad, Director, Chief Executive Officer, around April 01, 2024, sold 32,718 shares in Cardlytics (CDLX) for $448,020. Following the Form 4 filing with the SEC, Temsamani Karim Saad has
Cardlytics Inc (CDLX) CEO Karim Temsamani Sells 32,718 Shares
Cardlytics Inc (CDLX) Chief Legal & Privacy Officer Nicholas Lynton Sells 12,460 Shares
Why Cardlytics Stock Skyrocketed 75% Last Month
BRAG, IHRT Among Major Communication Services Gainers; DRCT, RDDT Among Losers
Is Cardlytics Stock a Buy After Insider's $13.9M Investment?
One stock that has been the target of heavy insider buying lately is Cardlytics (CDLX), with a major stakeholder dropping multi-millions on the shares this March after a long period of inactivity.
Analysis
Price Target
No Data
